Insights on the Global Oxaliplatin Injection Market to 2027 | Industry Statistics, Emerging Demands, Forecast to 2027

The global oxaliplatin injection market is expected to grow at a significant CAGR during the forecast period (2021-2027). Oxaliplatin, also known as Eloxatin, is a cancer treatment that is used to treat colorectal cancer. In advanced cancer, it’s frequently used with fluorouracil and folinic acid. It is administered through a venous injection. The rising prevalence of colorectal cancer owing to sedentary lifestyles such as obesity, consumption of alcohol, lack of physical activity, and tobacco consumption has been the major factor driving the market growth. Colorectal cancer is the fourth leading cause of cancer-related mortalities globally. As per the World Health Organization (WHO), the number of new colorectum cancer patients of both sexes of all ages in 2020 was around 1.9 million globally, which is 10% of new cancer cases. 

To Request a Sample of our Report on Global Oxaliplatin Injection Market:  https://www.omrglobal.com/request-sample/oxaliplatin-injection-market

Additionally, the increasing geriatric population and rising colorectal cancer associated with them is another factor driving the market growth. Moreover, the high prevalence of smokers and alcohol consumers who are most prone to this cancer has been boosting the market. For instance, as per the Centers for Disease Control and Prevention, in 2019, around 14 of every 100 US adults of age 18 years or above smoked cigarettes, which is 14% or 34.1 million adults. Apart from this, in November 2020, Swedish cancer society received grants for nearly $2 million for two research projects concerning colorectal cancer. Thus, the rising prevalence of cancer coupled with investment and grants for cancer research and treatment is expected to further contribute to the growth of the global oxaliplatin injection market. 

Market Coverage

·        The market number available for – 2020-2027

·        Base year- 2020

·        Forecast period- 2021-2027

·        Segment Covered

·        Regions Covered- Globally

·        Competitive Landscape:  Pfizer Inc., Sun Pharmaceutical Industries Ltd., Sanofi SA, and Teva Pharmaceuticals Industries Ltd. among others. 

(Get 15% Discount on Buying this Report)

A full Report of Global Oxaliplatin Injection Market is Available at:  https://www.omrglobal.com/industry-reports/oxaliplatin-injection-market

Global Oxaliplatin Injection Market Report by Segment

By Type 

•             Mannitol

•             Glucose Solution

•             Lactose Solution

•             Others

By Application 

•             Colorectal Cancer

•             Stomach Cancer

•             Ovarian Cancer

•             Others

Global Oxaliplatin Injection Market by Region

North America

·        United States

·        Canada

Europe

·        UK

·        Germany

·        Spain

·        France

·        Italy

·        Rest of Europe

Asia-Pacific

·                  India

·                  China

·                  Japan

·                  South Korea

·                  Rest of APAC

Rest of the World

·        Latin America 

·        Middle East & Africa

Reasons to buy from us –

1.  We cover more than 15 major industries, further segmented into more than 90 sectors.

2.  More than 120 countries are for analysis.

3.  Over 100+ paid data sources mined for investigation.

4.  Our expert research analysts answer all your questions before and after purchasing your report.

About Orion Market Research 

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404

(This release has been published on Global Market Post. Global Market Post is not responsible for any content included in this release.)

Leave a Reply

Your email address will not be published. Required fields are marked *